Select Equity Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $61.8M | Sell |
255,989
-9,191
| -3% | -$2.22M | 0.26% | 67 |
|
2025
Q1 | $64.6M | Sell |
265,180
-195,478
| -42% | -$47.6M | 0.28% | 60 |
|
2024
Q4 | $151M | Sell |
460,658
-247,794
| -35% | -$81.4M | 0.6% | 47 |
|
2024
Q3 | $237M | Buy |
708,452
+58,930
| +9% | +$19.7M | 0.85% | 36 |
|
2024
Q2 | $177M | Buy |
649,522
+134,856
| +26% | +$36.8M | 0.7% | 39 |
|
2024
Q1 | $178M | Buy |
514,666
+322,242
| +167% | +$111M | 0.63% | 42 |
|
2023
Q4 | $62.1M | Buy |
192,424
+134,798
| +234% | +$43.5M | 0.22% | 68 |
|
2023
Q3 | $20.7M | Sell |
57,626
-42,954
| -43% | -$15.4M | 0.08% | 99 |
|
2023
Q2 | $38.1M | Buy |
+100,580
| New | +$38.1M | 0.14% | 90 |
|
2019
Q1 | – | Sell |
-59,550
| Closed | -$13.8M | – | 89 |
|
2018
Q4 | $13.8M | Sell |
59,550
-127,373
| -68% | -$29.6M | 0.1% | 77 |
|
2018
Q3 | $58.5M | Buy |
186,923
+142,604
| +322% | +$44.6M | 0.43% | 51 |
|
2018
Q2 | $12.8M | Buy |
+44,319
| New | +$12.8M | 0.1% | 78 |
|
2017
Q1 | – | Sell |
-46,174
| Closed | -$8.42M | – | 91 |
|
2016
Q4 | $8.42M | Sell |
46,174
-20,367
| -31% | -$3.71M | 0.07% | 81 |
|
2016
Q3 | $10.9M | Sell |
66,541
-17,224
| -21% | -$2.82M | 0.09% | 89 |
|
2016
Q2 | $12M | Sell |
83,765
-2,109
| -2% | -$302K | 0.11% | 82 |
|
2016
Q1 | $11.7M | Buy |
85,874
+44,031
| +105% | +$6.02M | 0.1% | 83 |
|
2015
Q4 | $5.8M | Sell |
41,843
-8,717
| -17% | -$1.21M | 0.06% | 97 |
|
2015
Q3 | $6.79M | Sell |
50,560
-15,500
| -23% | -$2.08M | 0.06% | 97 |
|
2015
Q2 | $9.95M | Sell |
66,060
-41,038
| -38% | -$6.18M | 0.09% | 89 |
|
2015
Q1 | $14.5M | Sell |
107,098
-98,134
| -48% | -$13.3M | 0.13% | 85 |
|
2014
Q4 | $24.7M | Buy |
+205,232
| New | +$24.7M | 0.23% | 67 |
|